Fisher & Paykel Healthcare Corporation Limited (FSPKF)
Fisher & Paykel Healthcare Corporation Limited operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Auckland, AU, NZ. The stock last traded at $26.99, up 0.00% on the session, giving a market capitalisation of $15.88B. On trailing twelve-month figures it carries a trailing P/E of 61.61, a net margin of 20.0%. Its beta of 0.89 implies it has historically moved less than the broad market.
Operating globally, Fisher & Paykel Healthcare Corporation Limited specializes in the development, manufacturing, and marketing of a wide array of medical device products and systems. These solutions are primarily utilized for acute and chronic respiratory care, during surgical procedures, and in the treatment of obstructive sleep apnea (OSA) within both hospital and home environments. Key offerings include the Airvo 2, a humidified nasal high flow system; Optiflow, for nasal high flow therapy; and the F&P 850 System, which facilitates noninvasive and invasive ventilation. The company also provides a comprehensive range of infant respiratory products, encompassing devices for resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy. Its extensive hospital product portfolio features humidification equipment, breathing circuits, chambers, various masks, nasal cannulas, surgical components, and different interfaces and accessories. For homecare, Fisher & Paykel Healthcare supplies masks, CPAP devices, data management software, humidifiers, and related accessories. Established in 1934, the company is headquartered in Auckland, New Zealand.
Fisher & Paykel Healthcare Corporation Limited is most often compared with the following Healthcare names: